The Cardiovascular Research Foundation (CRF) has announced the late-breaking clinical science that will be presented at TCT 2022. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine.
News | TCT
CRF Announces TCT 2022 Late-breaking Clinical Science

August 4, 2022 — The Cardiovascular Research Foundation (CRF) has announced the late-breaking clinical science that will ...

Home August 04, 2022
Home
The Global Defibrillator Market size was valued at $11.30 billion in 2021 and is predicted to reach $21.09 billion by 2030
News | Defibrillator Monitors
Defibrillator Market Size Projected to Reach $21B by 2030

August 3, 2022 — A defibrillator administers a therapeutic shock to a patient's heart in life-threatening circumstances ...

Home August 03, 2022
Home
Christopher White, MD, System Chairman for Cardiovascular Disease Director and Director of John Ochsner Heart & Vascular Institute
News | Stents Carotid
JACC Study Makes Case for Expanding Coverage for Carotid Artery Stenting

August 3, 2022 — Research from Ochsner Health published in the Journal of the American College of Cardiology is likely ...

Home August 03, 2022
Home
Valentin Fuster, MD, PhD
News | TCT
Top TCT 2022 Award Recipients announced by Cardiovascular Research Foundation (CRF)

August 2, 2022 — Two significant awards will be presented at TCT 2022, to be held in Boston, Sept. 16-19, 2022. Career ...

Home August 02, 2022
Home
An advanced form of cardiac MRI, developed by academics at UCL in collaboration with the Royal Free Hospital, has for the first-time enabled clinicians to measure the effectiveness of chemotherapy in patients with the life-limiting condition ‘stiff heart syndrome’.
News | Magnetic Resonance Imaging (MRI)
Advanced MRI benefits Patients with Heart Stiffening Disease

August 2, 2022 — An advanced form of cardiac MRI, developed by academics at UCL in collaboration with the Royal Free ...

Home August 02, 2022
Home
About one percent of the world population is born with a congenital heart defect, which affects about 40,000 U.S. births each year, but how these particular birth defects come about is largely unknown.
News | Congenital Heart
New Study Provides Insight for How Congenital Heart Defects Manifest

August 2, 2022 — About one percent of the world population is born with a congenital heart defect, which affects about ...

Home August 02, 2022
Home
A study from the University of Warwick has found that school-based defibrillators (AEDs) that are accessible outside of school hours could be effective in treating over two thirds of Out of Hospital Cardiac Arrests (OHCAs) within five minutes
News | Defibrillator Monitors
Accessible Defibrillators in Schools Could Treat Two-thirds of Out of Hospital Cardiac Arrests

August 1, 2022 — A study from the University of Warwick has found that school-based defibrillators (AEDs) that are ...

Home August 01, 2022
Home
More than one in four pregnancy-related deaths (26.5%) in the U.S. are tied to poor heart health, especially among people of color, putting both parents-to-be and their babies at risk, according to the American Heart Association Heart Disease and Stroke Statistics 2022 Update.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: What Viewers Were Reading in July

Here is what you and your colleagues found to be most interesting in the fields of diagnostic and interventional ...

Home August 01, 2022
Home
Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ceiling, a ceiling-mounted angiography system designed for a wide range of routine and advanced procedures in interventional radiology (IR) and cardiology
News | Mobile C-Arms
Siemens Healthineers Announces FDA Clearance of ARTIS Icono Ceiling Angiography System

July 29, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ...

Home July 29, 2022
Home
RADIANCE II US FDA IDE pivotal trial evaluating the Paradise Ultrasound Renal Denervation (uRDN) System as a treatment for hypertension met its primary efficacy endpoint, demonstrating a statistically significant reduction in daytime ambulatory systolic blood pressure between treatment and a sham procedure measured at two months
News | Hypertension
ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise System for the Treatment of Hypertension

July 29, 2022 — ReCor Medical, Inc. and Otsuka Medical Devices Co., Ltd., a fully owned subsidiary of Otsuka Holdings Co ...

Home July 29, 2022
Home
AF occurring after noncardiac surgery may be triggered by perioperative stress and systemic inflammation in patients with predisposing comorbidities
News | Atrial Fibrillation
Atrial Fibrillation After Non-Cardiac Surgery Is Common and Not Benign

July 29, 2022 — A cohort study of persons with incident atrial fibrillation (AF) has found that AF after noncardiac ...

Home July 29, 2022
Home
a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, used experimental models to discover that a natural product found in plants including safflower holds promise for treating a pair of hereditary sudden cardiac death syndromes
News | Embolization devices
Instylla Announces Positive Results From Preclinical Studies of Embrace Hydrogel Embolic System in Hemorrhage Models 

July 28, 2022 — Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...

Home July 28, 2022
Home
a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, used experimental models to discover that a natural product found in plants including safflower holds promise for treating a pair of hereditary sudden cardiac death syndromes
News | Atherectomy Devices
Northeast Scientific Inc. wins 510(k) for Turbo-Elite Laser Atherectomy Catheter reprocessing

July 28, 2022 — Northeast Scientific Inc., pioneers in reprocessing single use peripheral vascular catheters, announced ...

Home July 28, 2022
Home
a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, used experimental models to discover that a natural product found in plants including safflower holds promise for treating a pair of hereditary sudden cardiac death syndromes
News | Sudden Cardiac Arrest
Main Line Health, Mayo researchers find natural product may prevent sudden cardiac death from rare inherited syndromes

July 28, 2022 — In 2020, a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part ...

Home July 28, 2022
Home
Human Chest Cavity illustration: Right lung, left lung, heart. Copyright American Heart Association
News | Coronavirus (COVID-19)
Coronavirus Spike Protein Activated Natural Immune Response, Damaged Heart Muscle Cells 

July 27, 2022 — Heart damage is common among patients hospitalized with COVID-19, leading many to wonder how the virus ...

Home July 27, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now